Valuation : Aprogen Biologics Inc.

Market Cap 2.41TCr 1.8Cr 1.55Cr 1.46Cr 1.33Cr 2.49Cr 171.55Cr 2.5Cr 17Cr 6.69Cr 87Cr 6.74Cr 6.6Cr 275.78Cr P/E 2024
-0.79x
P/E 2025 -0.6x
Enterprise Value 20TCr 15Cr 13Cr 12Cr 11Cr 21Cr 1.43TCr 21Cr 145.46Cr 56Cr 729.66Cr 56Cr 55Cr 2.31TCr EV / Sales 2024
3.66x
EV / Sales 2025 3.82x
Free-Float
42.08%
Yield 2024 *
-
Yield 2025 -
1 day+0.48%
1 week-7.24%
Current month-6.72%
1 month-21.17%
3 months-34.80%
6 months-60.02%
Current year-78.43%
1 week 1,616
Extreme 1616
1,940
1 month 1,616
Extreme 1616
2,455
Current year 1,616
Extreme 1616
8,490
1 year 1,616
Extreme 1616
9,945
3 years 1,616
Extreme 1616
67,500
5 years 1,616
Extreme 1616
2,04,750
10 years 1,616
Extreme 1616
8,58,000
Manager TitleAgeSince
Chief Executive Officer 63 13/10/2023
Chief Executive Officer 70 01/04/2012
Sales & Marketing 62 -
Director TitleAgeSince
Director/Board Member 70 01/04/2012
Director/Board Member 65 23/03/2020
Director/Board Member 63 13/10/2023
Date Insider Type Main position Quantity % Market Cap. Importance
28/06/24 Exercice

Executive/Senior Manager

6,183 0.0046%
28/06/24 Expiration

Chief Executive Officer

21,884 0.0164%
28/06/24 Exercice 11,846 0.0089% -
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%-7.24%-82.86%-97.36% 1.8Cr
-0.65%-2.93%+47.70%+86.17% 99TCr
-0.29%-3.51%+49.15%+62.35% 64TCr
+0.83%+0.26%+17.76%+72.25% 45TCr
-0.38%-3.59%+30.13%+35.17% 34TCr
-0.09%-13.54%+13.34%+24.95% 26TCr
-0.43%-2.48%-0.73%+9.58% 25TCr
-1.34%-13.70%+36.53%+44.96% 20TCr
-3.44%-7.51%-20.63%-59.44% 19TCr
-0.75%-4.82%+25.46%+87.14% 18TCr
Average -0.61%-5.95%+11.59%+26.58% 35.05TCr
Weighted average by Cap. -0.51%-4.42%+30.96%+54.95%

Financials

2024 2025
Net sales 6.74TCr 5.03Cr 4.33Cr 4.1Cr 3.72Cr 6.97Cr 480.21Cr 7.01Cr 49Cr 19Cr 244.31Cr 19Cr 18Cr 771.99Cr 7.32TCr 5.46Cr 4.71Cr 4.46Cr 4.04Cr 7.58Cr 521.89Cr 7.62Cr 53Cr 20Cr 265.52Cr 21Cr 20Cr 839Cr
Net income -10TCr -7.83Cr -6.75Cr -6.39Cr -5.79Cr -11Cr -748.2Cr -11Cr -76Cr -29Cr -380.65Cr -29Cr -29Cr -1.2TCr -17TCr -13Cr -11Cr -10Cr -9.4Cr -18Cr -1.21TCr -18Cr -123.12Cr -47Cr -617.61Cr -48Cr -47Cr -1.95TCr
Net Debt 12TCr 8.63Cr 7.44Cr 7.04Cr 6.38Cr 12Cr 824.6Cr 12Cr 84Cr 32Cr 419.52Cr 32Cr 32Cr 1.33TCr 18TCr 13Cr 11Cr 11Cr 9.77Cr 18Cr 1.26TCr 18Cr 128.06Cr 49Cr 642.39Cr 50Cr 49Cr 2.03TCr
Logo Aprogen Biologics Inc.
Aprogen Biologics Inc, formerly Aprogen Pharmaceuticals Inc, is a Korea-based company principally engaged in the pharmaceutical business. The Company operates its business through two segments. The Medicine Business segment is engaged in the manufacture and sale of central nervous system drugs, autonomic agents, arteriosclerosis agents, metabolic agents, circulatory system drugs, biopharmaceuticals and others. The Segment is also engaged in the manufacture and sale of cosmetics such as skin moisturizers and others. The Gaming Business segment is engaged in the development and operation of role-playing games (RPGs).
Employees
262
Date Price Change Volume
11/26/11 ₩1,679.00 +0.48% 1,59,294
10/26/10 ₩1,671.00 +0.84% 1,73,795
09/26/09 ₩1,657.00 -2.87% 2,54,324
08/26/08 ₩1,706.00 -6.16% 4,68,312
07/26/07 ₩1,818.00 +0.44% 7,87,223
  1. Stock Market
  2. Stocks
  3. A003060 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!